I agree that this site is using cookies. You can find further informations here.
X
Pishvaian, Michael J
139  results:
Search for persons X
?
1

Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 9078..:

Yoo, Changhoon ; Lamarca, Angela ; Choi, Hye Jin...
Future Oncology.  20 (2024)  16 - p. 1069-1077 , 2024
Link: https://doi.org/10.2217/..
 
?
2

First-in-human phase 1 study of the arginase inhibitor INCB..:

Naing, Aung ; Papadopoulos, Kyriakos P ; Pishvaian, Michael J...
BMJ Oncology.  3 (2024)  1 - p. e000249 , 2024
Link: https://doi.org/10.1136/..
 
?
3

Clinical outcomes of liposomal irinotecan in advanced pancr..:

Gupta, Amol ; De Jesus-Acosta, Ana ; Zheng, Lei...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit i..:

Chen, Kuei-Ting ; Madison, Russell ; Moore, Jay...
The Oncologist.  28 (2023)  8 - p. 691-698 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Molecular Profiling and Precision Medicine for Pancreatic C..:

, In: Pancreatic Cancer: A Multidisciplinary Approach,
Pishvaian, Michael J. ; Brody, Jonathan R. - p. 255-267 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Safety, tolerability and efficacy of agonist anti-CD27 anti..:

Sanborn, Rachel E ; Pishvaian, Michael J ; Callahan, Margaret K...
Journal for ImmunoTherapy of Cancer.  10 (2022)  8 - p. e005147 , 2022
Link: https://doi.org/10.1136/..
 
?
7

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:

Kim, Tae Won ; Burris III, Howard A. ; de Miguel Luken, Maria J....
Clinical Cancer Research.  28 (2022)  16 - p. 3452-3463 , 2022
Link: https://doi.org/10.1158/..
 
?
8

A phase I trial of the mTOR inhibitor temsirolimus in combi..:

Trivedi, Neel D. ; Armstrong, Samantha ; Wang, Hongkun...
Cancer Medicine.  10 (2021)  6 - p. 1944-1954 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Envisioning the future of precision oncology trials:

Madhavan, Subha ; Beckman, Robert A. ; McCoy, Matthew D....
Nature Cancer.  2 (2021)  1 - p. 9-11 , 2021
Link: https://doi.org/10.1038/..
 
?
10

Cadherin 11 Promotes Immunosuppression and Extracellular Ma..:

Peran, Ivana ; Dakshanamurthy, Sivanesan ; McCoy, Matthew D....
Gastroenterology.  160 (2021)  4 - p. 1359-1372.e13 , 2021
Link: https://doi.org/10.1053/..
 
?
11

Treatment patterns and outcomes in pancreatic cancer: Retro..:

Doleh, Yunes ; Lal, Lincy S. ; Blauer‐Petersen, Cori..
Cancer Medicine.  9 (2020)  10 - p. 3463-3476 , 2020
Link: https://doi.org/10.1002/..
 
?
12

A Phase I Study of Ribociclib Plus Everolimus in Patients w..:

Weinberg, Benjamin A. ; Wang, Hongkun ; Witkiewicz, Agnieszka K....
Journal of Pancreatic Cancer.  6 (2020)  1 - p. 45-54 , 2020
Link: https://doi.org/10.1089/..
 
?
13

Upfront molecular profiling of pancreatic cancer patients –..:

Bhutani, Manoop S. ; Cazacu, Irina M. ; Roy-Chowdhuri, Sinchita..
Pancreatology.  20 (2020)  3 - p. 391-393 , 2020
Link: https://doi.org/10.1016/..
 
?
14

A Phase Ib Study of Single-Agent Idelalisib Followed by Ide..:

Borazanci, Erkut ; Pishvaian, Michael J. ; Nemunaitis, John...
The Oncologist.  25 (2020)  11 - p. e1604-e1613 , 2020
Link: https://doi.org/10.1634/..
 
?
15

A step towards personalizing next line therapy for resected..:

Lowder, Cinthya Y. ; Dhir, Teena ; Goetz, Austin B....
Surgical Oncology.  33 (2020)  - p. 118-125 , 2020
Link: https://doi.org/10.1016/..
 
1-15